MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517069499 A) filed by Quethera Limited, Addlestone, U.K., on July 21, for 'recombinant adeno-associated virus vector.'
Inventor(s) include Adachi, Kenjiro; and Kozono, Naoki.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The invention provides adeno-associated virus (rAAV) vectors, in particular rAAV vectors comprising a genetic construct harbouring genes encoding tyrosine receptor kinase B (TrkB) and Brain Derived Neurotrophic Factor (BDNF). The invention also extends to a pharmaceutical composition comprising the rAAV vectors, and to the use of such vectors and compositions in gene therapy methods for preventing or treating a range of optic nerve disorders and cochlear disorders, or for promoting nerve regeneration and/or survival. The invention also provides methods of producing the rAAV vectors."
The patent application was internationally filed on Feb. 01, 2024, under International application No.PCT/GB2024/050275.
Disclaimer: Curated by HT Syndication.
